Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
170.94
-0.24 (-0.14%)
Nov 28, 2025, 4:00 PM EST - Market closed
Repligen Employees
Repligen had 1,778 employees as of December 31, 2024. The number of employees decreased by 5 or -0.28% compared to the previous year.
Employees
1,778
Change (1Y)
-5
Growth (1Y)
-0.28%
Revenue / Employee
$398,138
Profits / Employee
$978
Market Cap
9.63B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,778 | -5 | -0.28% |
| Dec 31, 2023 | 1,783 | -242 | -11.95% |
| Dec 31, 2022 | 2,025 | 173 | 9.34% |
| Dec 31, 2021 | 1,852 | 724 | 64.18% |
| Dec 31, 2020 | 1,128 | 367 | 48.23% |
| Dec 31, 2019 | 761 | 213 | 38.87% |
| Dec 31, 2018 | 548 | 72 | 15.13% |
| Dec 31, 2017 | 476 | 240 | 101.69% |
| Dec 31, 2016 | 236 | 68 | 40.48% |
| Dec 31, 2015 | 168 | 32 | 23.53% |
| Dec 31, 2014 | 136 | 20 | 17.24% |
| Dec 31, 2013 | 116 | -4 | -3.33% |
| Dec 31, 2012 | 120 | -17 | -12.41% |
| Dec 31, 2011 | 137 | 69 | 101.47% |
| May 6, 2010 | 68 | -1 | -1.45% |
| May 31, 2009 | 69 | 13 | 23.21% |
| May 27, 2008 | 56 | 11 | 24.44% |
| Jun 30, 2007 | 45 | 2 | 4.65% |
| Jun 6, 2006 | 43 | 6 | 16.22% |
| Jun 7, 2005 | 37 | -3 | -7.50% |
| Jun 7, 2004 | 40 | -4 | -9.09% |
| May 15, 2003 | 44 | 5 | 12.82% |
| May 15, 2002 | 39 | -1 | -2.50% |
| May 15, 2001 | 40 | 13 | 48.15% |
| May 15, 2000 | 27 | 3 | 12.50% |
| May 15, 1999 | 24 | 0 | - |
| May 29, 1998 | 24 | 4 | 20.00% |
| May 15, 1997 | 20 | 5 | 33.33% |
| Jun 14, 1996 | 15 | -89 | -85.58% |
| Mar 31, 1995 | 104 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RGEN News
- 2 days ago - Repligen Corporation to Present at Evercore Healthcare Conference - GlobeNewsWire
- 10 days ago - Repligen Corporation (RGEN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - Repligen Corporation (RGEN) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 14 days ago - Repligen: Rare Growth In The Biopharma Supplies Industry - Seeking Alpha
- 17 days ago - Repligen Corporation (RGEN) Presents at Stifel 2025 Healthcare Conference Transcript - Seeking Alpha
- 18 days ago - Repligen Corporation (RGEN) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Repligen Corporation (RGEN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance - GlobeNewsWire